세계의 폐암 수술 시장 : 수술 기기, 수술 절차, 최종 사용자별 예측(2025-2030년)

The Lung Cancer Surgery Market was valued at USD 5.69 billion in 2023, expected to reach USD 6.01 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 8.50 billion by 2030.

The scope and definition of lung cancer surgery encompass various surgical procedures aimed at removing cancerous tissues from the lungs, which is critical in managing early-stage lung cancers and improving survival rates. This field involves techniques such as lobectomy, wedge resection, segmentectomy, and pneumonectomy, with thoracotomy and minimally invasive approaches like video-assisted thoracoscopic surgery (VATS) and robotic surgery being crucial. The necessity of lung cancer surgery arises from its role as a curative treatment for non-small cell lung cancer (NSCLC) in localized stages, often complemented by chemotherapy or radiotherapy. Its application extends to both curative and palliative care, where surgery alleviates symptoms in advanced cancer stages. The main end-users include hospitals, specialty clinics, and cancer care centers. Market insights suggest growth is driven by rising lung cancer prevalence, advancements in surgical techniques, increasing adoption of minimally invasive surgeries, and supportive healthcare policies. However, challenges include high surgical costs, risks related to surgical complications, and the need for highly skilled surgeons. Potential opportunities lie in emerging markets, growing healthcare infrastructure, and technological innovations like AI and robotics in surgery. Recommendations include focusing on expanding minimally invasive procedures, enhancing post-surgical care, and developing cost-effective surgical solutions. Limitations stem from the need for improved patient selection and better integration of multimodal therapies. The market also faces the challenge of early diagnosis, which is vital for surgical eligibility. Innovation opportunities exist in personalized surgery approaches, leveraging genomic data to improve outcomes, and advancements in surgical tools enhancing precision. The nature of the lung cancer surgery market is competitive, with an increasing emphasis on technological advancements and collaborations to optimize treatment efficacy while focusing on patient-centric approaches and cost management to drive growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lung Cancer Surgery Market

The Lung Cancer Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of lung cancer coupled with growing trend of smoking tobacco
  • Increasing emphasis on early diagnosis & treatment of cancers
  • Growing adoption of minimally invasive techniques
• Market Restraints
  • High cost of lung cancer diagnosis & treatments
• Market Opportunities
  • Rising technological advancements in lung cancer treatment
  • Availability of reimbursements policies and government support for cancer treatments
• Market Challenges
  • Shortage of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Lung Cancer Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lung Cancer Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lung Cancer Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lung Cancer Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lung Cancer Surgery Market

A detailed market share analysis in the Lung Cancer Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lung Cancer Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lung Cancer Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lung Cancer Surgery Market

A strategic analysis of the Lung Cancer Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter Healthcare Corporation, FusionKraft Surgical Instruments, Henry Schein, Inc., Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC by STERIS plc, KLS Martin Group, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Surgical Devices, market is studied across Endo Surgical Equipment, Monitoring & Visualizing Systems, and Surgical Instruments. The Monitoring & Visualizing Systems is further studied across Cameras & Video Support and Endoscopic Trocars with Optical Views. The Surgical Instruments is further studied across Hand Instruments and Powered Surgical Equipment. The Hand Instruments is further studied across Clamps, Cutters, Elevators, Foreceps, Retractors, Rib Shears, Scissors, Staplers, and Trocar.
• Based on Surgical Procedures, market is studied across Minimally Invasive Surgeries and Thoracotomy. The Thoracotomy is further studied across Lobectomy, Pneumenectomy, Segmentectomy, and Sleeve Resection.
• Based on End-user, market is studied across Hospitals and Specialized Cancer Treatment Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
    • 5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
    • 5.1.1.3. Growing adoption of minimally invasive techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of lung cancer diagnosis & treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising technological advancements in lung cancer treatment
    • 5.1.3.2. Availability of reimbursements policies and government support for cancer treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of trained professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
  • 5.2.2. Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lung Cancer Surgery Market, by Surgical Devices

• 6.1. Introduction
• 6.2. Endo Surgical Equipment
• 6.3. Monitoring & Visualizing Systems
  • 6.3.1. Cameras & Video Support
  • 6.3.2. Endoscopic Trocars with Optical Views
• 6.4. Surgical Instruments
  • 6.4.1. Hand Instruments
    • 6.4.1.1. Clamps
    • 6.4.1.2. Cutters
    • 6.4.1.3. Elevators
    • 6.4.1.4. Foreceps
    • 6.4.1.5. Retractors
    • 6.4.1.6. Rib Shears
    • 6.4.1.7. Scissors
    • 6.4.1.8. Staplers
    • 6.4.1.9. Trocar
  • 6.4.2. Powered Surgical Equipment

7. Lung Cancer Surgery Market, by Surgical Procedures

• 7.1. Introduction
• 7.2. Minimally Invasive Surgeries
• 7.3. Thoracotomy
  • 7.3.1. Lobectomy
  • 7.3.2. Pneumenectomy
  • 7.3.3. Segmentectomy
  • 7.3.4. Sleeve Resection

8. Lung Cancer Surgery Market, by End-user

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Specialized Cancer Treatment Centers

9. Americas Lung Cancer Surgery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Lung Cancer Surgery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Lung Cancer Surgery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology
  • 12.3.2. Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia
  • 12.3.3. Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Inc.
• 2. Ackermann Instrumente GmbH
• 3. AngioDynamics Inc.
• 4. Baxter Healthcare Corporation
• 5. FusionKraft Surgical Instruments
• 6. Henry Schein, Inc.
• 7. Intuitive Surgical Inc.
• 8. Johnson & Johnson Services, Inc.
• 9. KARL STORZ GmbH
• 10. Key Surgical LLC by STERIS plc
• 11. KLS Martin Group
• 12. Koninklijke Philips N.V.
• 13. Medtronic PLC
• 14. Olympus Corporation
• 15. Richard Wolf GmbH
• 16. Scanlan International Inc.
• 17. Siemens Healthineers AG
• 18. Sontec Instruments Inc.
• 19. Teleflex Incorporated
• 20. TROKAMED GmbH
• 21. Wexler Surgical Inc.